Intranasal CO2 for Allergic Rhinitis

Trial Profile

Intranasal CO2 for Allergic Rhinitis

Phase of Trial: Phase II

Latest Information Update: 11 May 2017

At a glance

  • Drugs Carbon dioxide (Primary)
  • Indications Allergic rhinitis; Grass pollen hypersensitivity; Ragweed pollen hypersensitivity
  • Focus Therapeutic Use
  • Sponsors Capnia
  • Most Recent Events

    • 03 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top